Costos de la Diabetes en Ameŕica Latina- Evidencias del Caso Mexicano

Jul 1, 2011, 00:00
10.1016/j.jval.2011.05.022
https://www.valueinhealthjournal.com/article/S1098-3015(11)01438-0/fulltext
Title : Costos de la Diabetes en Ameŕica Latina- Evidencias del Caso Mexicano
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01438-0&doi=10.1016/j.jval.2011.05.022
First page : S85
Section Title : Economic Analysis
Open access? : No
Section Order : 27

The main objective was to identify economic burden from epidemiological changes and expected demand for health care services for diabetes in México. The cost evaluation method to estimate direct and indirect costs was based on instrumentation and consensus techniques. To estimate the epidemiological changes for 2009-2011, three probabilistic models were constructed according to the Box-Jenkins technique. Comparing the economic impact in 2009 versus 2011 (p and $10,296,786 to Private Health Insurance (PHI). Conclusions: If the risk factors and the different health care models remain as they are currently in the institutions analyzed, the financial consequences would be of major impact for the pockets of the users, following in order of importance, social security institutions and finally Ministry of Health. Allocate more resources to promotion and prevention of diabetes will decrease the cost increase by decreasing the demand for treatment of complications.

Categories :
  • Cost/Cost of Illness/Resource Use Studies
  • Decision Modeling & Simulation
  • Diabetes/Endocrine/Metabolic Disorders
  • Economic Evaluation
  • Specific Diseases & Conditions
  • Study Approaches
Tags :
  • cambios epidemiológicos
  • diabetes
  • Impacto económico
  • pacientes
  • sistema de salud
Regions :
  • Latin America
ViH Article Tags :